Oruka Therapeutics, Inc. (ORKA) (CIK 0000907654) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001213900-26-041494
- Form
- CORRESP
- Filer
- Oruka Therapeutics, Inc. (ORKA) (CIK 0000907654)
- CIK
- 0000907654
- Ticker
- ORKA
- Filed
- 2026-04-08
- SIC industry
- 2834
- HQ
- Menlo Park, CA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/907654/000121390026041494/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer